ADAMI, Maristella
 Distribuzione geografica
Continente #
NA - Nord America 4.141
AS - Asia 3.384
EU - Europa 2.458
SA - Sud America 461
AF - Africa 246
Continente sconosciuto - Info sul continente non disponibili 54
OC - Oceania 3
Totale 10.747
Nazione #
US - Stati Uniti d'America 4.029
SG - Singapore 1.248
CN - Cina 995
VN - Vietnam 487
IE - Irlanda 455
SE - Svezia 437
IT - Italia 363
BR - Brasile 343
FI - Finlandia 307
UA - Ucraina 288
HK - Hong Kong 236
DE - Germania 208
ZA - Sudafrica 151
NL - Olanda 96
TR - Turchia 94
BD - Bangladesh 85
FR - Francia 85
CA - Canada 82
GB - Regno Unito 81
CI - Costa d'Avorio 56
AR - Argentina 51
JP - Giappone 37
RU - Federazione Russa 35
IN - India 32
TH - Thailandia 24
EC - Ecuador 22
IQ - Iraq 21
BE - Belgio 20
PL - Polonia 17
CZ - Repubblica Ceca 14
PK - Pakistan 14
ID - Indonesia 13
MX - Messico 13
PH - Filippine 12
VE - Venezuela 12
ES - Italia 11
MA - Marocco 11
UZ - Uzbekistan 11
AT - Austria 10
CL - Cile 10
IL - Israele 9
JO - Giordania 9
KR - Corea 8
CO - Colombia 7
ET - Etiopia 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
NP - Nepal 6
EG - Egitto 5
JM - Giamaica 5
SA - Arabia Saudita 5
BO - Bolivia 4
GE - Georgia 4
LT - Lituania 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
GR - Grecia 3
HN - Honduras 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
RO - Romania 3
SN - Senegal 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GI - Gibilterra 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
Totale 10.692
Città #
Singapore 618
Ashburn 460
Dublin 452
Chandler 401
San Jose 340
Jacksonville 316
Santa Clara 309
Dearborn 267
Beijing 228
Hong Kong 213
Parma 184
Ann Arbor 181
Ho Chi Minh City 167
Nanjing 157
Dallas 153
Johannesburg 146
Boardman 124
Hanoi 107
Pittsburgh 85
Princeton 83
Izmir 80
Lauterbourg 71
Los Angeles 68
San Mateo 68
Shanghai 63
Wilmington 59
Council Bluffs 58
Abidjan 56
Toronto 46
New York 42
Nanchang 39
Shenyang 36
Buffalo 35
Woodbridge 31
Helsinki 30
Munich 30
São Paulo 29
Hefei 28
Kunming 25
Jiaxing 24
Moscow 23
Tokyo 23
Changsha 21
Hebei 21
Jinan 21
Tianjin 21
Brussels 20
Milan 20
Columbus 18
Guangzhou 18
Houston 18
Seattle 17
Da Nang 16
Haiphong 16
Hangzhou 16
The Dalles 16
Turku 15
Warsaw 15
Bangkok 13
Des Moines 13
Lucca 13
Brno 12
Auburn Hills 11
Tashkent 11
Frankfurt am Main 10
Norwalk 10
Ottawa 10
Rome 10
Brooklyn 9
London 9
Montreal 9
Naples 9
Phoenix 9
Amman 8
Baghdad 8
Brasília 8
Bremen 8
Dhaka 8
Düsseldorf 8
Hải Dương 8
Addis Ababa 7
Belo Horizonte 7
Campinas 7
Can Tho 7
Curitiba 7
Fremont 7
Hưng Yên 7
Leawood 7
Amsterdam 6
Augusta 6
Borås 6
Boston 6
Denver 6
Falls Church 6
Fuzhou 6
Guayaquil 6
Jakarta 6
Mumbai 6
Orange 6
Orem 6
Totale 6.586
Nome #
Treatments for COVID-19: emerging drugs against the coronavirus 255
Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties 214
CB1 and CB2 receptors and rat gastric acid secretion: "in vivo" study with selective agonists and antagonists 209
Involvement of histamine H1 and H4 receptors in a murine model of acute skin inflammation and pruritus 201
Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 – Triazine and 1H-indole like derivatives against the human histamine H4 receptor 199
Cannabinoid CB1 receptors and gastric acid secretion: in vivo and in vitro studies 188
Cannabinoid receptors and gastric acid secretion: a functional study in the rat 188
Comparison of pharmacological activity of hydrochloride salt and free base of putative histamine H4 ligands 187
CB1 and CB2 receptors and rat gastric acid secretion: "in vitro" study and immunoistochemical localization 177
Cannabinoid CB1 receptors are involved in the regulation of rat gastric acid secretion 177
Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice 174
Cardiac and gastric effects of hsitamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity 170
Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data. 169
Effects of histamine H4 receptor ligands in a mouse model of gastric ulceration 169
Central and peripheral histamine in gastric functions 168
Cannabinoid receptors and gastric acid secretion: a functional study in the rat 165
Gastroprotective effects of the selective histamine H4 receptor ligands ST-994 and ST-1012 in mouse in vivo model. 164
Effects of Cyclooxygenase-1 and -2 Inhibition on Gastric Acid Secretion and Cardiovascular Functions in Rats 164
Effects of the H4 receptor antagonist JNJ7777120 in mice: focus on strain-related differenes 163
Gastric and cardiovascular effects of COX-1 and COX-2 selective non steroidal anti-inflammatory drugs 160
Antiinflammatory, analgesic and gastroprotective effects of the novel and selective histamine H4-receptor antagonist VUF5949 152
Anti-inflammatory and gastroprotective effects of the H4 receptor antagonist JNJ7777120 in mice: focus on strain-related differences. 151
Gastric and cardiovascular effects of cox-1 and cox-2 selective nonsteroidal anti-inflammatory drugs 150
A new furoxan NO-donor rabeprazole derivative and related compounds 150
Gastroprotective effect of the histamine H4 receptor antagonist JNJ7777120 in mice 150
Effect of histamine H4 receptor ligands on cholinergic neurotransmission of the rat duodenum 150
Characterization of cholinoreceptors in the rat urinary bladder by the use of agonists and antagonists of the cholinergic system. 147
Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach 142
Synthesis and pharmacological characterization of new H2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities 142
Role of CB1-cannabinoid receptors in the regulation of rat gastric acid secretion 137
In situ investigation of the effects of icv application of cannabinoid receptor agonists on rat gastric acid secretion 136
Effects of new H4 receptor ligands: in vitro and in vivo studies 135
N-substituted piperidinyl alkyl imidazoles: discovery of a potent and highly selective histamine H3 receptor agonist 135
Antiinflammatory, analgesic and gastroprotective effects of the novel and selective histamine H4-receptor antagonist VUF5949 134
Effects of selective histamine H4 receptor ligands on croton oil-induced skin inflammation and pruritus in mice 134
Involvement of histamine H1 and H4 receptors in a murine model of acute skin inflammation and pruritus 133
Role of histamine H3 receptors in the regulation of gastric functions 132
Antisecretory and gastroprotective activities of a nitric oxide (NO)-releasing derivative of the proton pump inhibitor rabeprazole 132
Role of CB1-cannabinoid receptors in the regulation of rat gastric acid secretion 131
Effects of histamine H4 receptor agonists and antagonists on carrageenan-induced inflammation in rats 127
Neuronal histamine H3 receptors mediate antisecretory effects in the isolated rat gastric fundus 122
Antiinflammatory, analgesic and gastric effects of the novel and selective histamine H4-receptor antagonists VUF10214 and VUF10148 121
Pharmacological evidence for beta3 adrenoceptors in the control of rat gastric acid secretion 119
Nitric oxide-releasing rabeprazole: antisecretory and gastroprotective activities 118
Peripheral actions and therapeutic potential in periphery 118
Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat 118
Comparison of the in Vitro and in Vivo H2-H4 receptor selectivity of 4-methylhistamine and VUF 8430 117
Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation 116
Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat 116
Strain-dependent effects of the histamine H(4) receptor antagonist JNJ7777120 in a murine model of acute skin inflammation 111
Histamine H3 receptors mediate antisecretory effects in the isolated rat stomach 110
Inhibitory effects of the beta3-adrenoceptor agonists SR58611A and BRL37344 on rat gastric acid secretion 110
Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430 110
Histamine in cancer 109
Investigation of CB1 cannabinoid receptors mediating antisecretory effects in rat stomach 108
Histamine H3 receptors are involved in the protective effect of ghrelin against HCl-induced gastric damage in rats 106
Role of histamine H4 receptors in the gastrointestinal tract 106
Neuronal histamine H3 receptors mediate antisecretory effects in the rat isolated gastric fundus 105
Synthesis of 1,2-benzisothiazole derivatives and investigation of their putative histaminergic activity 105
Gastroprotective effects of histamine H4 receptor ligands in rodent ulcer models 105
Gastric effects of the histamine H4 receptor antagonists JNJ7777120 and VUF6002. 104
Fragment optimization leading to H4 receptor ligands with differential pharmacology 102
Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach. 98
Effects of histamine H3 and H4 receptor ligands in the rodent gastric mucosa 98
Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists 98
Measurement of gastric acid secretion in the anaesthetized rat 96
Functional and histologic assessment of rat gastric mucosa after chronic treatment with sulphurous thermal water 95
The histamine H4 receptor: a new target for gastrosparing anti-inflammatory drugs? 93
Involvement of histamine H3 receptors in the gastro-protection induced by ghrelin in the conscious rat 92
Mixed antisecretory and gastroprotective activities of a new H2- antagonist containing a nitric oxide-donor furoxan moiety 91
Gastric effects of the highly selective histamine H3 receptor agonist methimepip. 89
Histamine H4 receptors are not involved in the regulation of cholinergic neurotransmission in the rat duodenum 88
Further observations of the inhibitory effect of the disodium salt of 9-hydroxy-8,12-trans-19,20-bis-norprostanoic acid (rosaprostol) on gastric secretion. 87
Gastric effects of Histamine: any role for H4 receptors? 85
Gastroprotective effects of selective histamine H3 receptor agonists methimepip and immethridine 84
Probing the histamine H4 receptor binding site: from fragments to active ligands 84
Human defunctionalized colon: a histopathological and pharmacological study ofmuscularis propria in resection specimens 84
The histamine H4 receptor: a new target for GI safe anti-inflammatory drugs 82
The Histamine H4 Receptor: A Novel Target for Safe Anti-inflammatory Drugs? 82
Selective histamine H3 and H4 receptor agonists exert opposite effects against the gastric lesions induced by HCl in the rat stomach 82
Effects of histamine H4 receptor ligands on rodent models of acute inflammation 75
Histamine H4 receptor affinity of 1,3,5-triazine derivatives. 74
Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo 73
Totale 10.747
Categoria #
all - tutte 36.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022468 0 1 3 20 22 20 131 61 20 38 35 117
2022/20231.603 188 171 100 144 102 195 28 85 524 9 43 14
2023/2024472 23 48 16 5 45 84 48 34 25 47 33 64
2024/20251.739 89 101 105 75 238 218 37 67 201 164 116 328
2025/20263.844 352 294 410 375 538 265 383 151 457 343 224 52
2026/2027108 83 25 0 0 0 0 0 0 0 0 0 0
Totale 10.747